Wellai

In April 2020, a group of internationally recognized data scientists developed WellAI, a COVID-19 research tool. Powered by a new self-learning AI engine, it reads and interprets medical studies with high accuracy, covering health conditions. The WellAI team, breaking traditional AI boundaries, expanded their baseline tool with four additional neural networks. This expansion enabled the assimilation of over 30 million peer-reviewed medical articles, journals, case studies, and it continues to assimilate new publications as they emerge. The result is a multidisciplinary diagnostic solution that addresses practically every known health condition, from the common cold to rare diseases. The tool allows physicians and patients to simply speak their condition in a Siri-like fashion. WellAI ‘listens’ and cuts through the white noise of emotion and non-essential context to derive and translate medical symptoms into a diagnosis. Based on an initial set of symptoms, it asks logically derived questions to medically clarify how the patient is feeling, much like a medical practitioner during patient intake. It arrives rapidly at an initial diagnosis, usually in less than 2 minutes, limiting the diagnostic outcome to one or two most probable health outcomes. WellAI provides a logical and scientifically validated starting point, or a scientific second opinion, for a physician or medical practitioner to begin the process of diagnostic validation and to create a prescriptive treatment plan. The WellAI solution is presented in two forms: a Digital Health Assistant, represented as an “app” that can be downloaded onto a smartphone, computer, or iPad, which a physician, patient, or caregiver can use anywhere, anytime; and as an AI engine. The AI engine is the neural net/AI technology, which can be repurposed or used on the backend to power or enhance other solutions, like a front office workflow screening or EHR enhancement. https://WellAI.health